Thermochemotherapy in adjuvant treatment of primary high risk non muscle invasive bladder cancers: Single center results.

CONCLUSIONS: The obtained data suggest that the TCT method can be used effectively and safely in non-muscle invasive bladder cancers of primary high-risk. Prospective randomized studies will shed light on this subject which are BCG vs TCT in primary high risk patients and second course BCG vs TCT in the BCG insufficient patients. PMID: 26437330 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/26437330?dopt=Abstract

Source: Archivos Espanoles de Urologia - December 21, 2015 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research